SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017198
Filing Date
2019-05-08
Accepted
2019-05-08 16:11:30
Documents
56
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ubx-10q_20190331.htm 10-Q 2117137
2 EX-10.1 ubx-ex101_114.htm EX-10.1 28884
3 EX-31.1 ubx-ex311_6.htm EX-31.1 18076
4 EX-31.2 ubx-ex312_8.htm EX-31.2 18059
5 EX-32.1 ubx-ex321_9.htm EX-32.1 14610
  Complete submission text file 0001564590-19-017198.txt   6603990

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ubx-20190331.xml EX-101.INS 1408921
7 XBRL TAXONOMY EXTENSION SCHEMA ubx-20190331.xsd EX-101.SCH 46862
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ubx-20190331_cal.xml EX-101.CAL 41101
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ubx-20190331_def.xml EX-101.DEF 148542
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20190331_lab.xml EX-101.LAB 338458
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20190331_pre.xml EX-101.PRE 265542
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38470 | Film No.: 19806714
SIC: 2834 Pharmaceutical Preparations